Doctor profile · Federal record
Dr. Mark Romer, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Medical Oncology Physician · Dayton, OH
- NPI 1023058427
- Accepts Medicare
- MIPS 85.1 / 100 · 2023
- 40 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
3120 Governors Place Blvd
Dayton, OH 454091328
(937) 293-1622
fax (937) 245-6308 - Additional location
-
2300 Miami Valley Dr Ste 150
Centerville, OH 454591294 - Mailing address
-
6680 Poe Ave Ste 200
Dayton, OH 454142855
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- January 7, 2022
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Ohio #35055583 · Ohio #35.055583
- Medicaid
- OH #0926225
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1023058427. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
62,518
Distinct HCPCS
10
Medicare allowed
$1,209,708
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 12,200 | 19 | $54 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 10,305 | 14 | $3 | |
J1453 |
Injection, fosaprepitant, 1 mg | 9,150 | 32 | $0 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 9,000 | 11 | $1 | |
J1756 |
Injection, iron sucrose, 1 mg | 6,000 | 20 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 5,040 | 35 | $23 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,500 | 28 | $0 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2,390 | 12 | $45 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,318 | 48 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 901 | 40 | $1 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 1,183. This provider delivers 53× the peer median.Open Payments
Industry payments received
All-time total
$3,105
Transactions
122
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 12 | $268.72 | |
| Novartis Pharmaceuticals Corporation | 18 | $252.69 | |
| AstraZeneca Pharmaceuticals LP | 11 | $232.05 | |
| PFIZER INC. | 15 | $230.45 | |
| Daiichi Sankyo Inc. | 13 | $213.72 | |
| Janssen Biotech, Inc. | 10 | $197.06 | |
| Merck Sharp & Dohme LLC | 9 | $191.39 | |
| Lilly USA, LLC | 6 | $133.75 | |
| Celgene Corporation | 6 | $113.48 | |
| Incyte Corporation | 5 | $112.37 | |
| Gilead Sciences, Inc. | 4 | $80.47 | |
| Genentech USA, Inc. | 4 | $72.99 | |
| Alexion Pharmaceuticals, Inc. | 4 | $69.50 | |
| TAIHO ONCOLOGY, INC. | 3 | $54.69 | |
| Zimmer Biomet Holdings, Inc. | 2 | $54.58 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,281
Patients
316
Total drug cost
$4,271,160
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Oxycodone Hcl | Generic | 155 | 36 | $3,443 |
| Anastrozole | Generic | 151 | 45 | $6,058 |
| Ibrance (Palbociclib) | Brand | 143 | 15 | $2,324,751 |
| Imbruvica (Ibrutinib) | Brand | 116 | 11 | $1,865,235 |
| Ondansetron Hcl | Generic | 104 | 41 | $1,476 |
| Dexamethasone | Generic | 99 | 33 | $1,152 |
| Letrozole | Generic | 98 | 19 | $5,185 |
| Prednisone | Generic | 69 | 22 | $422 |
| Hydroxyurea | Generic | 62 | 17 | $1,495 |
| Eliquis (Apixaban) | Brand | 61 | 17 | $40,582 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Romer's medical specialty?
Dr. Mark Romer practices Hematology & Oncology Physician in Dayton, OH.
Where does Dr. Mark Romer practice?
Dr. Mark Romer practices at 3120 Governors Place Blvd, Dayton, OH 454091328. Office phone: 9372931622.
What is Dr. Mark Romer's NPI?
Dr. Mark Romer's National Provider Identifier (NPI) is 1023058427, issued by NPPES.
Does Dr. Mark Romer accept Medicare assignment?
Yes. Dr. Mark Romer accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Romer commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.